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Context: ​Breathlessness is common in people with lung cancer. Non-pharmacological breathlessness 
interventions reduce ‘distress due to’ and increase ‘mastery over’ breathlessness.  
Objectives: ​Identify patient characteristics associated with response to breathlessness interventions. 
Methods: ​Exploratory secondary trial data analysis. Response defined as a 1-point improvement in 
0-10 numerical rating scale of worst breathlessness/last 24 hours (Response-Worst) or a 0.5-point 
improvement in the Chronic Respiratory Questionnaire (CRQ) Mastery (Response-Mastery) at 4 
weeks. Univariable regression explored relationships with plausible demographic, clinical and 
psychological variables followed by multivariable regression for associated (P-value <0.05) variables. 
Results: ​158 participants with intrathoracic cancer (mean age 69.4 [SD: 9.35] years; 40% women) 
were randomised to one or three breathlessness training sessions.​ ​ 91 had evaluable data for 
Response-Worst, and 107 for Response-Mastery. In the univariable analyses, the personality trait 
“openness” was associated with Response-Worst (Odds Ratio (OR) 1.99 [95% CI 1.08 to 3.67]; 
P-value=0.028) and Response-Mastery (OR = 1.84 [95% CI 1.04 to 3.23]; P-value=0.035). Higher 
CRQ-Fatigue (OR 0.61 [95% CI 0.41 to 0.91]: P=0.015), CRQ-Emotion (OR =0.68 [95% CI 0.47 to 0.96]: 
P-value=0.030) and worse CRQ-Mastery (OR =0.61 [95% CI 0.42 to 0.88]; P-value=0.008), and 
presence of metastases and fatigue were associated with reduced odds of Response-Mastery. In the 
adjusted Response-Mastery model, only “openness” remained (OR 1.73 [95% CI 0.95 to 3.15]; 
P-value = 0.072). 
Conclusions: ​Worse baseline health, worse breathlessness mastery, but not severity, and 
“openness” were associated with a better odds of response. Breathlessness services must be easy to 
access and patients encouraged and supported to attend.  
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KEY MESSAGE ​This planned exploratory secondary trial data analysis shows some evidence that the 
personality trait “openness” and worse breathlessness mastery are associated with benefit from a 




Chronic breathlessness (disabling and persistent despite optimised treatment for the causative 
condition​1​) has widespread impacts on those living with it and those who care for them.​ 2; 3;4;5 
Breathlessness is a multidimensional symptom that encompasses sensory, affective and cognitive 
components​6;7​  which interact with biological, psychological, social and environmental factors to 
influence behaviour.​2  
 
Breathlessness is common in people with lung cancer, affecting almost all with advanced disease.​8 
Despite appropriate use of anti-cancer treatments and management of complications, chronic 
breathlessness and frightening acute-on-chronic breathlessness​9​ remain the daily experience of 
many. Non-pharmacological interventions reduce distress due to and increase mastery over 
breathlessness,​10​ even with single training sessions.​11​ However, given that engaged self-management 
by the patient is important, little is known about the characteristics of individuals more likely to 
benefit. The way a person copes with and seeks help for chronic breathlessness seems to be related 
to their ability to experience the best quality of life despite their limitations.​2;12 
 
A recent secondary pooled data analysis of three randomised controlled trials (RCT) of complex 
breathlessness interventions​13​ explored predictors of better breathlessness outcomes. Overall, about 
one-third of participants had lung cancer. The only predictor of improvement in mastery was worse 
baseline mastery and the only predictor of improvement in distress due to breathlessness was worse 
baseline distress.  However, candidate variables were limited by those available in the contributing 
datasets; the only psychological variables measured were mastery and emotional domains of the 
Chronic Respiratory Questionnaire and anxiety and depression (Hospital Anxiety Depression Scale).  
 
We evaluated the cost-effectiveness of a single or three breathing training session(s) in people with 
intrathoracic cancer; the single session was as effective as three for breathlessness severity and was 
better in terms of distress due to breathlessness.​11​ An ​a priori​ objective was to explore the 
relationship between patient psychological characteristics at baseline and their response to 
breathing training.  The null hypothesis was that there would be no evidence of association between 





Secondary data analysis 
The parent trial is reported in detail elsewhere​11​ but is summarised here. Consecutive patients with 
chronic breathlessness due to active intra-thoracic malignancy, were recruited into a phase III 
multi-centre, pragmatic, individually randomised, non-blinded parallel arm RCT of single session 
versus three hour-long sessions of breathing training at weekly intervals. Patients with chronic 
breathlessness, self-reported breathlessness ​>​3/10 (0 = no breathlessness; 10 = worst imaginable 
breathlessness), and a clinician-estimated prognosis ≥3 months were eligible.  Patients with 
intercurrent illness or co-morbidities making trial completion unlikely, or prior breathing training 
were excluded.  All participants gave written informed consent. 
3 
 
The trial was prospectively registered (ISRCTN49387307).  Ethical approval was given by Sheffield 
Research Ethics Committee (ref 10/H1308/66) including for the method of consent.  Institutional 
approval was gained from each site prior to recruitment.  
 
Baseline and outcome measures 
In addition to the primary outcome, measure of patient-reported intensity of the worst 
breathlessness over the past 24 hours (‘worst’), specific psychological measures of interest at 
baseline (Box 1) were the Big Five Inventory (BFI)​14​ and Mental Toughness Questionnaire (MTQ-48)​15​, 
Chronic Respiratory Questionnaire-Self-Administered-Survey (CRQ-SAS)​16​, Hospital Anxiety and 
Depression Scale (HADS)​17​, Brief COPE​18​, Catastrophic thinking and perceived Injustice Experiences 
Questionnaire (CIEQ-Chr – 1-5 IEQ, 6-12 PCS)​19​ and numerical rating scales (NRS) for coping with and 
distress due to breathlessness. Health status (Euroqol [EQ-5D] and EQ-visual analogue scale 
(EQVAS)​20​, and the Karnofsky Performance Scale (KPS)​21​ were also measured. 
 
<<insert Box 1 about here>> 
 
Definition of response for this study 
We considered two binary outcome measures. Firstly, Response-worst (yes/no) was derived using an 
improvement of 1 point or more (yes) from baseline assessment to week 4 on the ‘worst’ 
breathlessness scale over past 24 hours .​22​ Secondly, CRQ-SAS Mastery was used to determine 
patient response (Response-mastery: yes/no), using an improvement of 0.5 from baseline 
assessment to week 4 (yes).​23  
 
Explanatory variables 
Explanatory variables with rationale for use are shown in Box 2. 
 
<<insert Box 2 about here>> 
 
Statistical analysis 
Percentages of responders (Yes) and non-responders (No) by baseline characteristics are presented 
for categorical variables. Whereas, means and standard deviations are presented for continuous 
variables.  Furthermore, we present summary statistics for baseline characteristics for those whose 
outcome was missing.  
We used logistic regression to explore univariable associations of response at baseline. The primary 
dependent variables were Response-Worst and Response-Mastery. Explanatory independent 
variables included ‘Demographic characteristics’, ‘Intervention characteristics’, ‘Cancer-related 
variables’ and ‘Psychological Variables’ as shown in Box 2, drawn from the literature or from 
plausible biological explanation.  A multiple logistic regression model was then built from 
significantly associated variables (P-value <0.05).  Odds ratios were provided in addition to 95% 
Confidence Intervals (CI) and P-values. In this exploratory analysis, we did not ​adjust for multiple 








One hundred and fifty-six participants (mean age 69.4 [9.35] years; 40% women) were randomised 
(1:2 randomisation, 52 to three sessions, 104 to single session).  Primary lung cancer was the most 
common diagnosis in 133 (85.3 %), 12 (8%) had mesothelioma (data not shown). Two withdrew from 
each arm prior to the intervention and were excluded from the analysis. At 4 weeks 124/156 (79%) 
participants were still in the trial. Details are presented elsewhere.​11 
 
There were 91 participants with baseline and week 4 data evaluable for Response-Worst, of whom 
47/91 (60%) were responders, and 107 for Response-Mastery (49/107; 46% responders). 
Characteristics according to response are shown in Online Supplementary Table 1. The univariable 
analyses showing a relationship between variables and Response –Worst or Response-Mastery with 
evidence of a statistically significant relationship are shown in Table 1. 
 
<<insert Table 1 about here>> 
 
 
Predictors of Response-Worst breathlessness 
No demographic, intervention or cancer variables showed evidence of relationship to response at 
the statistical significance level of 0.05.  Participants who were more open and saw things as a 
challenge were more likely to respond to the intervention, in addition to those who employed denial 
or sought out emotional support as a way of coping. Some evidence (​P-values between 0.05 and 
0.1) ​of a relationship was observed for the explanatory variable “Openness”. 
 
Predictors of Response-Mastery over breathlessness 
As with Response-worst, we had no evidence that demographic or intervention variables were 
predictive of Response-mastery. With this outcome, some disease characteristics did show some 
evidence of relationship. People with worse self-reported health status, no metastases, and less 
fatigue were more likely to respond.  
 
When considering the psychological variables, BFI “Openness” was again predictive of response. 
With the CRQ, worse baseline breathlessness levels and worse emotional function were associated 
with a better response. Those who used “humour” as a way of coping, were less likely to respond.  
 
 
A multiple regression model (see Table 3) was only built for Response-Mastery as ​only 'Openness' 
was significantly associated with Response-worst. ​ In the adjusted analysis, none of the 
explanatory variables had a P-value < 0.05. In addition, ​a correlation matrix was prepared for 
the explanatory variables included in the multiple logistic model. Openness was not 
correlated to any CRQ SAS variables whereas the CRQ scales were statistically significantly 
correlated to each other although not highly (data not shown, available on request). 
 






In this planned exploratory analysis, we found some evidence that the personality trait of 
“openness” was associated with both response in severity of breathlessness and mastery over 
breathlessness. Cancer metastases and presence of fatigue, and worse baseline CRQ mastery and 
emotional function also predicted better gains in mastery in the univariable analyses. Some ways of 
coping showed weak relationships with better severity response in those using denial and emotional 
support but a worse mastery response in those using humour.  
 
Brighton ​et al​, found a similar proportion of responders (60% “worst”; 50% “mastery”) and that 
worse baseline mastery predicted greater likelihood of response.​13​ As the authors discuss, this could 
be regression to the mean, but is unlikely to be the sole explanation given the effect sizes observed 
and consistent findings across similar trials,​10​ and similar interventions (some improvements from 
pulmonary rehabilitation were greatest in those with worse baseline disease burden).​26​ It is also 
consistent with our finding that those with worse self-reported health were more likely to respond, 
although the extent of cancer and degree of fatigue appeared to limit potential; intuitively 
understandable given the physical effort needed to practice the self-management techniques. It is 
also notable that in the parent trial, distress due to breathlessness was worse in the group attending 
three sessions, which may indicate a burden of intervention.​11​ Some sites delivered 
home-intervention to minimise this, but the findings remained despite stratification by site.  
 
Patients’ ways of coping, approach to seeking help and their expectations of both the symptom and 
of success of self-management affect how well people live with chronic breathlessness due to a 
number of cardio-respiratory causes.​2;27​ An engaged style of coping (problem solving, findings ways 
to maintain role and activities despite limitations) appears to support daily living well,​2​ and 
“optimism” and “hardiness” helps promote resilience and self-management in people with 
acute-on-chronic breathlessness crises.​12​ This narrative is consistent with our finding that patients 
with a higher level of “challenge” (the extent to which people identify problems as ways for 
self-development; arguably an important attribute in being “hardy”) and “openness” to trying new 
things were more likely to respond for both outcomes. Such open-mindedness could protect against 
the assumption that “nothing will help”.​28​ Of note, we found that those using “denial” also may be 
more likely to be a responder (worst breathlessness). Although counterintuitive, perhaps, as denial 
can be seen as a way of protecting oneself from being overwhelmed by the stressor, those who can 
use denial with regard to breathlessness, may be more likely to engage with training. For example, 
even though training could make breathlessness worse in the immediate term, patients might use 
denial to overcome that threatening situation,​29​ although if this is so, it is surprising not to see an 
association with active coping as well.  However, use of denial to protect against threat, combined 
with “openness” and “challenge”, would make an interesting psychological profile. Personality and 
coping also seem to be integrally related.​30​ Personality may affect type of coping strategy used, or 
nuance and effectiveness of use directly through biological drives, or in response to experiences of 
stressors.​31​ In patients with lung cancer the trait of neuroticism and helplessness/hopelessness 
coping styles were strongly linked with increased anxiety;​32​ a driver for breathlessness. 
 
Functional imaging has increased our understanding of the role of prior bad experiences and mood 
in forming brain networks, and how they influence the perception of breathlessness in a “Bayesian” 
manner.​27​ Thus the inference of what the brain expects and the sensory inputs the brain actually 
receives will result in the patient’s perception of breathlessness. People who are less likely to 




Strengths and limitations 
The ​a priori​ design, prospectively collecting a range of personality traits and coping style data at 
baseline is a strength. The main limitation is the exploratory nature of the design and the number of 
tests conducted. Also, for these observational data, only association rather than causation can be 
apportioned. As a secondary analysis of data collected from trial participants, the representativeness 
of the findings are limited by the trial’s eligibility criteria. Although these were broad, the same 
characteristics that may help patients do well with self-management interventions, may also be 
associated with those prepared to be enrolled in a clinical trial. However, we did have a range of 
personality and coping styles represented in the dataset.​11  
 
Implications for clinical practice and research 
The patients who benefited most, seem to be those with the worst self-reported health status and 
breathlessness. However, these may be those most reluctant to attend, and services should be easy 
to get to and patients encouraged and supported. Compassionately challenging fears and negative 
expectations may help improve benefit to that seen in people with a more open, positive view of life.  
These data are exploratory and therefore not directly clinically-translatable, but provide sufficient 
signal to warrant further investigation of the impact of personality and coping on responses to 
complex interventions that require self-management efficacy. In particular, the combination of 





Patients with worse subjective health status, worse baseline breathlessness mastery, but not 
severity, and the personality trait “openness” are most likely to respond to worst breathlessness and 
mastery following a breathlessness intervention. Presence of metastases and worse fatigue reduce 
the likelihood of benefit. Breathlessness services must be easy to get to and patients encouraged 
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Box 1 Psychological measures 
Measure Description 
Big Five Inventory​14 46 item statements with 5 point Likert scale to assess degree of 
agreement (1 disagree strongly; 5 strongly agree) 
Self-report inventory intended to measure an individual on the Big Five 
Factors (dimensions) of personality (Extraversion, Neuroticism, 
Agreeableness, Conscientiousness and Openness) 
Mental Toughness 
Questionnaire​15 
48 item statements with a 5 point Likert scale to assess degree of 
agreement. (1 disagree strongly; 5 strongly agree) 
Intended to measure the proposed four core components of mental 
toughness (control, challenge, commitment and confidence) 
Chronic Respiratory 
Questionnaire​16 
20- items. A list of 5 standardised activities is given and the patients 
asked to rate the level of breathlessness caused by these on a 7 point 
Likert scale.  
The patient is then asked in a similar manner regarding energy levels, 
mood and feeling of control over their illness and breathing. 
Total score and subscores on 4 categories (dyspnoea, fatigue, 
emotional function, mastery); ​Higher scores indicate better 
health-related quality of life. 
Hospital Anxiety and 
Depression Scale​17 
A widely used 14 item (7 for depression scoring 0 -3, 7 for anxiety scoring 
0 - 3) screening tool for depression and anxiety. Higher scores indicate 
worse anxiety or depression. 
Brief COPE​18 A 28-item multidimensional measure of strategies used for coping or 
regulating cognitions in response to stressors, each rated (1 = I haven’t 
been doing this at all to 4 = I have been doing this a lot) 







A 12-item scale that asks respondents to indicate the frequency with 
which they experience different thoughts concerning the sense of 
unfairness in relation to their injury on a 5-point scale with the endpoints 
(0) ​never ​and (4) ​all the time​. 
Numerical Rating Scale 
– COPE* 
0 to 10 numerical rating scale, “How well have you ​coped ​with your 
breathlessness on average over the past 24 hours?”; 0 =I have not coped 
at all;  10 = I have coped very well 
Numerical Rating Scale 
– DISTRESS* 
0 to 10 numerical rating scale, How much ​distress ​has your 
breathlessness caused you on average over the past 24 hours?”; 0 = No 






Box 2. Explanatory variables with rationale 




● Sex  
 
● Breathlessness is more prevalent in 
older people​24 
● Breathlessness is more commonly 




● Study arm – low/high 
● Study site 
● Some individuals may respond to 
different intensities of intervention 
even though the group estimate was 
of no difference 
● Study sites varied with the 
composition of their breathlessness 
intervention teams and components 




● Performance/health status: 
o KPS* 
o EQ-5D* 
● Physical extent of disease: 
o Presence of metastases 
(yes/no) 
o Smoking (never/ever) 
● Symptoms: 
o NRS Average* 
o CRQ-Dyspnoea*, 
CRQ-Fatigue* 
All of these may affect the ability of the 






● Study arm Preference  
● CRQ-Emotion, CRQ-Mastery 
● NRS Cope,  
● NRS Distress 
● BFI domains * 
● HADS (Anxiety, depression) 
● MTQ-48 (Commitment, 
Control, Challenge, 
Confidence) * 
● Brief COPE (All 14 scales)* 
● Catastrophizing and Injustice 
All of these factors may affect the ability of 
the patient to engage with the 
intervention  
* KPS - Karnofsky Performance Scale; EQ-5D – Euroqol; BFI - Big Five Inventory; MTQ-48 - Mental Toughness 
Questionnaire, CRQ-SAS - Chronic Respiratory Questionnaire; HADs - Hospital Anxiety and Depression Scale; 






Online Supplementary Table 1: Descriptive statistics by response status for worst breathlessness 
and mastery and for those with missing outcomes.  
 

















N (%) 47 (48) 44 (52) 91 64  49 (46) 57 (54) 107 
Age​ * 69.5 (9.93) 70 (9.95) 69.7 (9.89) 68.5 (8.41)  68.8 (8.44) 69.9 (10.39) 69.4 (9.52) 
Sex 
Female 23 (50) 16 (37) 39 (43) 22 (33.85)  18 (37) 26 (46) 44 (42) 
 Male 23 (50) 28 (64) 51 (57) 41 (63)  31 (63) 31 (54) 62 (59) 
Study Arm         
 High 14 (30) 18 (41) 32 (35) 20 (31)  19 (39) 18 (31) 37 (35) 
Low 33 (70) 26 (59) 59 (65) 45 (69)  30 (61) 40 (69) 70 (65) 
Study Site         
Cambridge 5 (10.64) 2 (5) 7 (8) 5 (8)  4 (8) 3 (5) 7 (7) 
Cardiff 9 (19.15) 7 (16) 16 (18) 8(12)  7 (14) 9 (16) 16 (15) 
Coventry 3 (6.38 8 (18) 11 (12) 4 (6)  5 (10) 6 (10) 11 (10) 
East Kent 14 (29.79) 9 (21) 23 (25) 5 (8)  11 (22) 12 (21) 22 (22) 
Edinburgh 0 (0) 1 (2) 1 (1) 1 (2)  0 (0) 1 (2) 1 (1) 
Glasgow 5 (10.64) 1 (2) 6 (7) 19 (29)  11 (22) 11 (19) 22 (21) 
Hull 6 (12.77) 10 (23) 16 (18) 17 (26)  5 (10) 11(19) 16 (15) 
West Kent 5 (10.64) 6 (14) 11 (12) 6 (9)  6 (12) 5 (9) 11 (10) 





73.41 (9.11) 72.86 
(8.44) 
66.9 (10.17)  72.77 (7.72) 72.83 (8.18) 72.8 (7.92) 
EQ5D VAS  57.78 
(18.05) 
59.27 (18.76) 58.52 
(18.30) 




        
Yes 9 (21) 4 (10) 13 (15) 10 (15)  3 (7) 11 (21) 14 (14) 
No 33 (79) 38 (90) 71 (85) 47 (72)  43 (94) 42 (79) 85 (86) 
Smoking​: N (%)         
Ever 39 (85) 41 (93) 80 (89) 60 (92)  44 (90) 50 (86) 94 (89) 
Never 7 (15) 3 (7) 10 (11) 3 (5)  5 (10) 7 (12) 12 (11) 
Numerical Rating Scales for breathlessness​: mean score (SD) 
Average 5.24 (1.72) 5.32 (1.39) 5.28 (1.56) 6.04 (1.77)  5.50 (1.57) 5.10 (1.50) 5.38 (1.54) 
Cope 7.00 (2.03) 7.00 (2.09) 7 (2.05) 6.44 (2.24)  6.88 (1.96) 7.12 (2.15) 7.01 (2.06) 
Distress 4.70 (2.80) 3.95 (2.71) 4.34 (2.76) 5.18 (3.31)  4.66 (2.82) 3.98 (2.77) 4.28 (2.80) 
Chronic Respiratory Questionnaire​: mean score (SD) 
Dyspnea 4.56 (1.33) 4.52 (1.22) 4.54 (1.27) 4.18 (1.26)  4.52 (1.12) 4.47 (1.33) 4.49 (1.23) 
Fatigue 3.28 (0.94) 3.35 (1.00) 3.31 (1.00) 3.07 (1.18)  3.08 (1.01) 3.58 (1.03) 3.35 (1.25) 
Emotion 4.57 (1.12) 4.62 (1.07) 4.59 (1.09) 4.08 (1.34)  4.33 (1.17) 4.81 (1.06) 4.59 (1.13) 
Mastery  4.46 (1.16) 4.56 (1.06) 4.51 (1.10) 3.96 (1.25)  4.16 (1.05) 4.75 (1.11) 4.48 (1.12) 
Arm Preference​: N (%) 
High 11 (23) 9 (20) 14 (22) 20 (22)  10 (20) 16 (28) 26 (24) 
Low 14 (30) 8 (18) 22 (24) 14 (22)  10 (20) 13 (22) 23 (22) 
None 22 (47) 27 (61) 49 (54) 36 (55)  29 (60) 29 (50) 58 (54) 
Big Five Inventory​: mean score (SD) 
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Extraversion 3.21 (0.88) 3.31 ( 0.80) 3.26 (0.84) 3.15 (0.75)  3.23 (0.75) 3.277 (0.87) 3.25 (0.81) 
Agreeableness 4.32 (0.49) 4.19 (0.54) 4.26 (0.52) 4.05 (0.69)  4.14 (0.57) 4.29 (0.51) 4.22 (2.67) 
Conscientiousne
ss 
4.16 (0.58) 4.11 (0.58) 4.14 (0.58) 3.99 (0.68)  4.14 (0.64) 4.05 (0.61) 4.09 (0.63) 
Neuroticism 2.44 (0.87) 2.39 (0.80) 2.42 (0.83) 2.76 (0.89)  2.54 (0.77) 2.40 (0.86) 2.46 (0.82) 
Openness 3.60 (0.68) 3.25 (0.75) 3.42 (0.73) 3.10 (0.65)  3.54 (0.69) 3.24 (0.71) 3.38 (0.72) 
Hospital Anxiety Depression Scale​: mean score (SD) 
Anxiety 6.02 (4.07) 5.82 (3.71) 5.92 (3.88) 7.43 (4.85)  6.59 (3.99) 5.74 (3.8) 6.13 (3.90) 
Depression 6.00 (3.31) 5.64 (3.70) 5.82 (3.49) 6.75 (3.95)  6.43 (3.51) 5.64 (3.36) 6.00 (3.44) 
Mental Toughness Questionnaire​: mean score (SD) 
Commitment 3.84 (0.61) 3.75 (0.66) 3.79 (0.63) 3.61 (0.64)  3.81 (0.53) 3.74 (0.70) 3.77 (0.63) 
Challenge 3.94 (0.67) 3.68 (0.62) 3.81 (0.65 3.66 (0.67)  3.86 (0.61) 3.69 (0.65) 3.77 (0.63) 
Emotion 3.20 (0.61) 3.34 (0.60 3.26 (0.61) 3.28 (0.68)  3.30 (0.67) 3.29 (0.62) 3.29 (0.64) 
Life 3.72 (0.67) 3.69 (0.65) 3.70 (0.66) 3.62 (0.70)  3.78 (0.64) 3.66 (0.73) 3.71 (0.65) 
Abilities 3.61 (0.62) 3.78 (0.53) 3.69 (0.58) 3.58 (0.64)  3.64 (0.58) 3.68 (0.61) 3.66 (0.59) 
Interpersonal 3.86 (0.82) 3.77 (0.72) 3.81 (0.77) 3.76 (0.79)  3.84 (0.72) 3.79 (0.80) 3.81 (0.76) 
BriefCOPE questionnaire:​ mean score (SD) 
self-distraction 4.83 (1.95) 4.79 (1.97) 4.80 (1.95) 4.85 (1.69)  4.84 (1.77) 4.70 (1.95) 4.76 (1.86) 
active coping 4.74 (1.84) 4.49 (2.02) 4.61 (1.92) 4.78 (1.53)  4.96 (1.68) 4.40 (1.96) 4.66 (1.85) 
denial 3.36 (1.86) 2.79 (1.06) 3.09 (1.55) 3.3 (1.75)  3.12 (1.67) 3.16 (1.59) 3.14 (1.62) 
substance use 2.53 (1.21) 2.35 (0.95 ) 2.44 (1.09) 2.7 (1.59)  2.35 (0.95) 2.57 (1.33) 2.47 (1.17) 
emotional 
support 
6.35 (1.85) 5.58 (1.93) 5.98 (1.91) 6.2 (1.67)  6.24 (1.94) 5.70 (1.83) 5.95 (1.89) 
instrumental 
support 





2.41 (1.11)  2.30 (0.74) 2.36 (0.94) 2.75 (1.30)  2.45 (1.02) 2.40 (1.07) 2.42 (1.04) 
venting 3.17 (1.52) 2.88 (1.38) 3.03 (1.46) 3.27 (1.36)  3.14 (1.51) 2.95 (1.39) 3.04 (1.48) 
positive 
reframing 
4.07 (1.85 ) 3.86 (1.70) 3.98 (1.77) 3.87 (1.55)  4.20 (1.78) 3.84 (1.61) 4.01 (1.69) 
planning 4.00 (1.80) 3.93 (1.80) 3.96 (1.79) 4.22 (1.69)  4.16 (1.87) 3.95 (1.66) 4.05 (1.76) 
humour 4.33 (2.04) 4.37 (2.10) 4.35 (2.06) 4.63 (2.28)  3.98 (2.15) 4.70 (2.00) 4.37 (2.09) 
acceptance 7.07 (1.14) 6.60 (1.69) 6.84 (1.45) 6.66 (1.40)  6.84 (1.50) 6.77 (1.34) 6.80 (1.41) 
religion 3.78 (2.08) 3.28 (2.06) 3.53 (2.07) 3.02 (2.00)  3.39 (2.13) 3.40 (1.95) 3.40 (2.03) 
self-blame 3.27 (1.66) 3.21 (1.64) 3.24 (1.64) 3.47 (1.70)  3.45 (1.56) 3.09 (1.64) 3.26 (1.60) 
Catastrophic thinking and perceived Injustice Experiences Questionnaire ​mean score (SD) 
Injustice 4.34 (2.61) 3.73 (2.75) 4.04 (2.68) 4.23 (2.74)  4.20 (2.54) 3.88 (2.51) 4.03 (2.52) 










Table 1. Univariable analyses (P values at the P <0.05 level shown in bold.) 
 
 Baseline values Response - Worst Odds Ratio 
(95% CIs) P value 
Response – Mastery 
Odds Ratio (95% CIs) P value 
Demographic 
Age 0.99 (0.95 to 1.04); p = 0.797 0.99 (0.95 to 1.03); P = 0.551 
Sex (man vs woman [ref]) 0.57 (0.25 to 1.33); p = 0.193 1.44 (0.66 to 3.15); P = 0.356 
Smoking (never vs ever[ref]) 2.45 (0.59 to 10.17); P = 0.216 0.81 (0.24 to 2.74); P = 0.737 
Intervention 
 Study arm (High vs low) 0.61 (0.26 to 1.46); P = 0.268 1.41 (0.63 to 3.13); P = 0.402 
    
 Study site vs Cambridge [ref] P=0.181 P=0.888 
 Cardiff 0.51 (0.08 to 3.49); P = 0.496 0.58 (0.10 to 3.51);  P = 0.556 
Coventry 0.15 (0.02 to 1.24); P = 0.078 0.63 (0.09 to 4.22); P = 0.630 
East Kent 0.62 (0.10 to 3.92); P = 0.614 0.69 (0.12 to 3.79); P = 0.667 
Glasgow 2 (0.13 to 29.81); P = 0.615 0.75 (0.14 to 4.17); P = 0.742 
Hull 0.24 (0.03 to 1.65); P = 0.147 0.34 (0.05 to 2.13); P = 0.250 
West Kent 0.33 (0.04 to 2.52); P = 0.287 0.90 (0.13 to 6.08); P = 0. 914 
Cancer related 
 Karnofsky Performance Status 0.98 (0.94 to 1.04); P = 0.553 1.0 (0.95 to 1.05); P = 0.968 
EuroQol- VAS 1.0 (0.97 to 1.02); P = 0.711 0.98 (0.96 to 1.00) ; P = 0.07 
Metastases (Yes vs No [ref]) 2.59 (0.73 to 9.20); P = 0.141 0.27 (0.07 to 1.02) ; P= 0.054  
Symptoms 
 NRS average  
 
0.97 (0.74 to 1.26); P = 0.809 1.19 (0.90 to 1.57); P = 0.220 
CRQ-Dyspnea 1.03 (0.74 to 1.42); P = 0.876 1.04 (0.76 to 1.41); P = 0.827 
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CRQ-Fatigue 0.93 (0.60 to 1.43); P = 0.727 0.61 (0.41 to 0.91); ​P = 0.015 
Psychological factors 
 Arm preference  P = 0.321 P=0.597 
 low vs high [ref] 1.43 (0.42 to 4.93); P = 0.570 1.23 (0.39 to 3.86); P = 0.722 
 None vs high [ref] 0.67 (0.23 to 1.90); P = 0.447 1.60 (0.62 to 4.11); P = 0.329 
 NRS cope 1.0 (0.82 to 1.22); P = 1.000 0.94 (0.77 to 1.16); P = 0.576 
NRS distress 1.11 (0.95 to 1.29); P = 0.200 1.09 (0.94 to 1.27); P = 0.258 
CRQ-Emotion 0.96 (0.66 to 1.41); P = 0.842 0.68 (0.47 to 0.96); ​P = 0.030 
CRQ-Mastery 0.92 (0.63 to 1.35); P = 0.681 0.61 (0.42 to 0.88); ​P = 0.008 
Big Five Inventory 
BFI Extraversion 0.87 (0.53 to 1.44); P = 0.587 0.94 (0.59 to 1.51);  P = 0.812 
BFI Agreeableness 1.64 (0.72 to 3.72); P = 0.239 0.59 (0.29 to 1.22);  P = 0.157 
BFI Conscientiousness 1.19 (0.58 to 2.45); P = 0.643 1.25 (0.67 to 2.33);  P = 0.482 
BFI Neuroticism 1.08 (0.65 to 1.79); P = 0.759 1.23 (0.77 to 1.97); P = 0.392 
BFI  Openness 1.99 (1.08 to 3.67); ​P = 0.028 1.84 (1.04 to 3.23); ​P = 0.035 
Hospital Anxiety Depression Scale 
Anxiety 1.01 (0.91 to 1.13); P = 0.802 1.06 (0.96 to 1.17); P = 0.261 
Depression 1.02 (0.92 to 1.16); P = 0.618 1.07 (0.96 to 1.20); P = 0.237 
Mental Toughness Questionnaire-48 
MTQ-48 Commitment 1.27 (0.65 to 2.47); P = 0.479 1.22 (0.66 to 2.26);  P = 0.523 
MTQ-48 Challenge 1.85 (0.95 to 3.62); P= 0.071 1.56 (0.84 to 2.91); P = 0.159 
MTQ-48 Emotion 0.67 (0.33 to 1.35); P = 0.261 1.03 (0.56 to 1.87);  P = 0.932 
MTQ-48 Life 1.06 (0.56 to 2.00); P = 0.859 1.34 (0.73 to 2.44); P = 0.340 
MTQ-48 Abilities 0.61 (0.29 to 1.27); P = 0.185 0.89 (0.47 to 1.69); P = 0.720 




self-distraction 1.01 (0.81 to 1.25); P = 0.931 1.04 (0.85 to 1.28); P = 0.708 
active coping 1.07 (0.86 to 1.33); P = 0.537 1.18 (0.95 to 1.46); P = 0.127 
denial 1.29 (0.96 to 1.74); P= 0.087 0.99 (0.78 to 1.25); P = 0.917 
substance use 1.17 (0.79 to 1.74); P = 0.429 0.84 (0.59 to 1.19); P = 0.332 
emotional support 1.24 (0.99 to 1.56); P = 0.062 1.17 (0.95 to 1.44); P = 0.142 
instrumental support 1.07 (0.86 to 1.35); P = 0.533 1.10 (0.89 to 1.36); P = 0.382 
behavioural disengagement 1.14 (0.72 to 1.80); P = 0.582 1.04 (0.72 to 1.51); P = 0.822 
venting 1.15 (0.86 to 1.55); P = 0.349 1.10 (0.84 to 1.43); P = 0.488 
positive reframing 1.07 (0.84 to 1.35); P = 0.585 1.14 (0.90 to 1.43); P = 0.272 
planning 1.02 (0.81 to 1.30); P = 0.851 1.07 (0.86 to 1.34); P = 0.527 
humour  0.99 (0.81 to 1.21); P = 0.916 0.84 (0.70 to 1.02); P =0.078 
acceptance 1.26 (0.93 to 1.71); P = 0.138 1.03 (0.79 to 1.36); P = 0.813 
religion 1.13 (0.92 to 1.39); P = 0.253 1.0 (0.82 o 1.20); P = 0.968 
self blame 1.02 (0.79 to 1.32);  P = 0.869 1.15 (0.90 to 1.47); P = 0.254 
Catastrophic thinking and perceived Injustice Experiences Questionnaire 
Injustice 1.09 0.93 to 1.28); P = 
0.276 
1.05 (0.90 to 1.23); P = 0.505 





Table 2. Adjusted and crude estimates using logistic regression for Response – outcome 
 
 Crude Odds Ratios (95% CIs) P 
value 
Adjusted Odds Ratios (95% CIs) P 
value 
Symptoms:CRQ-Fatigue 0.61 (0.41 to 0.91): ​P = 0.015 0.72 (0.44 to 1.19); P = 0.201 
CRQ-Emotion 0.68 (0.47 to 0.96): ​P = 0.030 1 (0.6 to 1.68); P = 0.995 
CRQ-Mastery  
 
0.61 (0.42 to 0.88); ​P = 0.008 0.69 (0.43 to 1.12); P = 0.132 
BFI  Openness 1.84 (1.04 to 3.23); ​P = 0.035 1.73 (0.95 to 3.15); P = 0.072 
P values at the P <0.05 level shown in bold.​  The crude estimates are those reported in Table 2 
but presented here for ease of comparison.  
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